MedTrace Logo

Lymph Node Mapping in Patients With Endometrial Cancer

NCT01818739 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 204

Last updated 2023-03-22

Study results available
· View outcomes & findings →

Summary

This clinical trial studies lymph node mapping in patients with endometrial cancer. Lymph node mapping may allow for limited removal of lymph nodes in as part of endometrial cancer staging and treatment.

Conditions

Interventions

PROCEDURE

sentinel lymph node detection

Undergo sentinel lymph node detection using fluorescence imaging with indocyanine green solution and isosulfan blue

DRUG

indocyanine green solution

Undergo sentinel lymph node detection using fluorescence imaging with indocyanine green solution and isosulfan blue

DRUG

isosulfan blue

Undergo sentinel lymph node detection using fluorescence imaging with indocyanine green solution and isosulfan blue

PROCEDURE

sentinel lymph node biopsy

Undergo sentinel lymph node biopsy

Sponsors & Collaborators

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Floor Backes, MD · Ohio State University Comprehensive Cancer Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2016-11-16
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01818739 on ClinicalTrials.gov